TATA健康(01255)接获联交所额外复牌指引 继续停牌
Group 1 - TATA Health (01255) announced that it received a letter from the Stock Exchange regarding additional guidance for the resumption of trading on September 4, 2025 [1] - The company is required to comply with Listing Rule 3.10(2) [1] - The company's shares remain suspended from trading [1]